Subscribe to our newsletter From Joe Burnett, President & CEO: This has been an incredible quarter of many ClearPoint firsts. I am delighted to share that we have now treated the first clinical trial patient…
Read More
Quarterly eNewsletter – September 2022 Edition
Subscribe to our newsletter From Joe Burnett, President & CEO: This past quarter our team, together with our partners, has achieved four significant regulatory milestones that impact both our Functional Neurosurgery and Biologics and Drug…
Read More
Quarterly eNewsletter – June 2022 Edition
Subscribe to our newsletter From Joe Burnett, President & CEO: Welcome to our Q2 newsletter. As you’ll see below, we have lots of terrific news to share. I’d like to start with news from our…
Read More
Quarterly eNewsletter – March 2022 Edition
Subscribe to our newsletter From Joe Burnett, President & CEO: In this first newsletter of 2022, I am delighted to celebrate some of our company’s 2021 successes. Last year, our talented Clinical Specialist and Operations…
Read More
Quarterly eNewsletter – December 2021 Edition
Subscribe to our newsletter From Joe Burnett, President & CEO: The closing of one year and opening of another provides an important interlude to take stock, and celebrate our team’s 2021 accomplishments. On the clinical…
Read More
Quarterly eNewsletter – September 2021 Edition
Subscribe to our newsletter From Joe Burnett, President & CEO: As summer draws to a close here in Southern California, we are excited to share a few updates from this past quarter. Last month, we…
Read More